Sprites
Mein FinanzNachrichtenJetzt AnmeldenPasswort vergessen?
Montag, 13.02.2012Börsentäglich über 11.000 News von 420 internationalen Medien
Erweiterte
Suche
Ad hoc-Mitteilungen

AASTROM BIOSCIENCES INC

1,354 Euro		-0,083
-5,78 %
WKN: A1CSSX  ISIN: US00253U3059  Ticker-Symbol: ATQN  Frankfurt | 10.02.12 | 12:06 Uhr
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
AASTROM BIOSCIENCES INC Chart 1 Jahr
1-Woche-Intraday-Chart
AASTROM BIOSCIENCES INC 1-Woche-Intraday-Chart

Aktuelle News zur AASTROM BIOSCIENCES Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
02.02. Relatively High Price to Forward Sales Detected in Shares of Aastrom Biosciences in the Biotechnology Industry3SmarTrend
24.01. Breakthrough Therapy Using Cord Blood Banking Driving Stem Cell Industry / Five Star Equities Provides Stock Research on Cord Blood America & Aastrom Biosciences102MarketWire
NEW YORK, NY -- (Marketwire) -- 01/24/12 -- Given some positive trends, the stem cell market could be set to skyrocket this year. A recent report from Kalorama Information titled "Worldwide Markets...
Mehr lesen zu:
Breakthrough Therapy Using Cord Blood Banking Driving Stem Cell Industry / Five Star Equities Provides Stock Research on Cord Blood America & Aastrom Biosciences
23.01. Aastrom's Renewed Momentum And Appreciation Before Anticipated Offering3Seeking Alpha
09.01. Stem Cell Therapy From Aastrom Biosciences and Cytori Therapeutics Looks to Gain Ground in 2012 / The Paragon Report Provides Equity Research on Aastrom Biosciences & Cytori Therapeutics105MarketWire
NEW YORK, NY -- (Marketwire) -- 01/09/12 -- Stem Cell stocks -- particularly companies focused on adult stems cells -- have performed well of late. Earlier this month Goldman Sachs noted the potential...
Mehr lesen zu:
Stem Cell Therapy From Aastrom Biosciences and Cytori Therapeutics Looks to Gain Ground in 2012 / The Paragon Report Provides Equity Research on Aastrom Biosciences & Cytori Therapeutics
15.12. Shares of Aastrom Biosciences Fall Below Previous 52-Week Low1SmarTrend
15.12. Aastrom Biosciences Looks to Continue to Trade Below its Annual-Low Share Price Today1SmarTrend
16.11. Breakthrough Stem Cell Therapy From Aastrom Biosciences and NeoStem Begins to Gain Ground / The Bedford Report Provides Equity Research on Aastrom Biosciences & NeoStem67MarketWire
NEW YORK, NY -- (Marketwire) -- 11/16/11 -- The case for increased stem cell funding is growing by the day as the potentially lifesaving effects of regenerative medicine continue to be revealed. Scientists...
Mehr lesen zu:
Breakthrough Stem Cell Therapy From Aastrom Biosciences and NeoStem Begins to Gain Ground / The Bedford Report Provides Equity Research on Aastrom Biosciences & NeoStem
14.11. UPDATE 1-Aastrom's cell therapy shows promise in trial1Reuters.com
14.11. Aastrom (ASTM) Reports Encouraging Results from ESTORE-CLI Phase 2; Meets Primary Safety Endpoint1StreetInsider.com
24.10. Edison Expands Cell Therapy Sector Presence with Launch of Research Coverage on Aastrom48Business Wire
Edison Investment Research, a UK-based independent equity research firm, announces the initiation of research coverage on Aastrom Biosciences, Inc (NASDAQ: ASTM), a US...
Mehr lesen zu:
Edison Expands Cell Therapy Sector Presence with Launch of Research Coverage on Aastrom
03.10. Aastrom Bio (ASTM) Receives Patent Protection for Ixmyelocel-T in EU5StreetInsider.com
19.09. Aastrom (ASTM) Reports Encouraging Results of IMPACT-DCM from 12-Month Follow Up2StreetInsider.com
14.09. Aastrom Biosciences (ASTM) to Present Ixmyelocel-T Data6StreetInsider.com
13 Nachrichten in den letzten 6 Monaten